These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 8457655

  • 21. Clot structure modification by fondaparinux and consequence on fibrinolysis: a new mechanism of antithrombotic activity.
    Varin R, Mirshahi S, Mirshahi P, Kierzek G, Sebaoun D, Mishal Z, Vannier JP, Yvonne Borg J, Simoneau G, Soria C, Soria J.
    Thromb Haemost; 2007 Jan; 97(1):27-31. PubMed ID: 17200767
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins.
    Bendayan P, Boccalon H, Dupouy D, Boneu B.
    Thromb Haemost; 1994 May; 71(5):576-80. PubMed ID: 8091383
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A reconstituted dilute blood clot lysis assay for the medium throughput screening of thrombolytic compounds.
    Gadbut AP, Schullek JR, Hanel AM, MacAllan DR.
    Anal Biochem; 1999 May 15; 270(1):24-32. PubMed ID: 10328761
    [Abstract] [Full Text] [Related]

  • 28. Direct microscopic monitoring of initial and dynamic clot lysis using plasmin or rt-PA in an in vitro flow system.
    Bizjak N, Bajd F, Vidmar J, Blinc A, Perme MP, Marder VJ, Novokhatny V, Serša I.
    Thromb Res; 2014 May 15; 133(5):908-13. PubMed ID: 24613694
    [Abstract] [Full Text] [Related]

  • 29. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis.
    van Giezen JJ, Boon GI, Jansen JW, Bouma BN.
    Thromb Haemost; 1993 Apr 01; 69(4):381-6. PubMed ID: 8497851
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effect of thrombin inhibition on the dynamics of thrombolysis and on platelet function during thrombolytic therapy.
    Rudd MA, George D, Johnstone MT, Moore RT, Collins L, Rabbani LE, Loscalzo J.
    Circ Res; 1992 Apr 01; 70(4):829-34. PubMed ID: 1551206
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets.
    Torr-Brown SR, Sobel BE.
    Thromb Res; 1993 Dec 01; 72(5):413-21. PubMed ID: 8303684
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.